Big Data
CASE STUDY: Why Pharmaceutical Market Access is Dependent on Risk Sharing and Persistency Modeling
ABSTRACT In our case study for injectable Migraine medication, the higher patient persistency curve for patients with a lower co-pay increases drug utilization by 20%, while lowering payor price by 26% and payor total cost by 11%. What is Market Access? It’s the process that ensures that all patients, who Read more…
You must be logged in to post a comment.